ArticleHemaSphere2025

Cumulative review of cardiac failure with acalabrutinib in the treatment of chronic lymphocytic leukemia using data from clinical trials and postmarketing experience.

Paolo Ghia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.